KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Shares Outstanding (2016 - 2025)

Cardlytics (CDLX) has disclosed Shares Outstanding for 10 consecutive years, with $54.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 6.35% year-over-year to $54.5 million, compared with a TTM value of $54.5 million through Dec 2025, up 6.35%, and an annual FY2025 reading of $54.5 million, up 6.35% over the prior year.
  • Shares Outstanding was $54.5 million for Q4 2025 at Cardlytics, up from $53.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $54.5 million in Q4 2025 and bottomed at $31.8 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $41.3 million, with a median of $37.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding decreased 0.43% in 2023, then surged 43.18% in 2024.
  • Year by year, Shares Outstanding stood at $33.5 million in 2021, then fell by 0.17% to $33.5 million in 2022, then rose by 18.67% to $39.7 million in 2023, then grew by 29.02% to $51.3 million in 2024, then grew by 6.35% to $54.5 million in 2025.
  • Business Quant data shows Shares Outstanding for CDLX at $54.5 million in Q4 2025, $53.8 million in Q3 2025, and $53.0 million in Q2 2025.